Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03362060
Brief Title: PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer

First Submitted : November 27, 2017
First Submitted that Met QC Criteria : December 2, 2017
First Posted : December 5, 2017

Last Update Submitted that Met QC Criteria : May 6, 2021
Last Update Posted : May 10, 2021